On July 29, 2016 Kyowa Hakko Kirin Co., Ltd., an R&D-based life sciences company with special strengths in biotechnology, reported financial results for the second quarter ended June 30, 2016 (Press release, Kyowa Hakko Kirin, JUL 29, 2016, View Source [SID:1234514125]). Schedule your 30 min Free 1stOncology Demo! Net worldwide sales for the second quarter of 2016 were 85.6 billions of yen, a 4% decrease from that of 89.2 billions of yen for the second quarter of 2015. Regional Sales for the second quarter of 2016 were as follows: Japan 60.7 bn yen, Americas 4.1 bn yen, Europe 13 bn yen, Asia, 7.6 bn yen and other regions amounted to 0.3 bn yen.
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
For Kyowa Hakko Kirin Co., Ltd’s detailed sales figures, visit: View Source